Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone)
Clinical trial NCT03638869 · COMPLETED
Trial details
- NCT number
- NCT03638869
- Sponsor
- Relmada Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-31
- Primary completion
- 2015-11-16
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.